Uptick In 4Q 2013 M&A Deal-Making Likely To Continue Into 2014, PwC Report Predicts

Earn-outs and other deal tools help bridge value gaps and share risk, enabling more deals to be finalized, report says. However, pharma is seeing increased M&A competition from biotechs looking to diversify and increase scale.